Graph Theory and Matrix Approach (GTMA) Model for the Selection of the Femoral-Component of Total Knee Joint Replacement
Non-Metallic Material Science · 2021
DOI: 10.30564/nmms.v3i1.3058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Non-Metallic Material Science, 2021. Verfasst von Amber Gul und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Total Knee Replacement (TKR) is the increasing trend now a day, in revision surgery which is associated with aseptic loosening, which is a challenging research for the TKR component. The selection of optimal material loosening can be controlled at some limits. This paper is going to consider the best material selected among a number of alternative materials for the femoral component (FC) by using Graph Theory. Here GTMA process used for optimization of material and a systematic technique introduced through sensitivity analysis to find out the more reliable result. Obtained ranking suggests the use of optimized material over the other existing material. By following GTMA Co_Cr-alloys (wrought-Co-Ni-CrMo) and Co_Cr-alloys (cast-able-Co-Cr-Mo)are on the 1st and 2nd position respectively.
Zitieren
APA
Gul, A., Mehmood, M. N., & Mehmood, M. S. (2021). Graph Theory and Matrix Approach (GTMA) Model for the Selection of the Femoral-Component of Total Knee Joint Replacement. Non-Metallic Material Science. https://doi.org/10.30564/nmms.v3i1.3058
Vancouver
Gul A, Mehmood MN, Mehmood MS. Graph Theory and Matrix Approach (GTMA) Model for the Selection of the Femoral-Component of Total Knee Joint Replacement. Non-Metallic Material Science. 2021. doi:10.30564/nmms.v3i1.3058
BibTeX
@article{Gul2021,
author = {Gul, Amber and Mehmood, Malik Naqash and Mehmood, Malik Sajjad},
title = {Graph Theory and Matrix Approach (GTMA) Model for the Selection of the Femoral-Component of Total Knee Joint Replacement},
journal = {Non-Metallic Material Science},
year = {2021},
doi = {10.30564/nmms.v3i1.3058}
}
EUVIMED